118 related articles for article (PubMed ID: 38591973)
41. Non-invasive tests for clinically significant portal hypertension after HCV cure.
Semmler G; Lens S; Meyer EL; Baiges A; Alvardo-Tapias E; Llop E; Tellez L; Schwabl P; Mauro E; Escudé L; Díez C; Ibañez-Samaniego L; Puente Á; Fortea JI; Abadía M; Zanetto A; Conthe A; Hernandez-Évole H; Luzko Scheid IS; Jia J; Yoshiji H; Francque SM; Tsochatzis EA; Russo FP; Crespo G; Forns X; Bañares R; Villanueva C; Hernández-Gea V; Reiberger T; Bosch J; García Pagán JC; Mandorfer M;
J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968
[TBL] [Abstract][Full Text] [Related]
42. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
[TBL] [Abstract][Full Text] [Related]
43. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
Ismail M
Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic accuracy of two-dimensional shear wave elastography in detecting hepatic fibrosis in children with autoimmune hepatitis, biliary atresia and other chronic liver diseases.
Galina P; Alexopoulou E; Mentessidou A; Mirilas P; Zellos A; Lykopoulou L; Patereli A; Salpasaranis K; Kelekis NL; Zarifi M
Pediatr Radiol; 2021 Jul; 51(8):1358-1368. PubMed ID: 33755748
[TBL] [Abstract][Full Text] [Related]
45. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.
Dajti E; Ravaioli F; Zykus R; Rautou PE; Elkrief L; Grgurevic I; Stefanescu H; Hirooka M; Fraquelli M; Rosselli M; Chang PEJ; Piscaglia F; Reiberger T; Llop E; Mueller S; Marasco G; Berzigotti A; Colli A; Festi D; Colecchia A;
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):816-828. PubMed ID: 37478880
[TBL] [Abstract][Full Text] [Related]
47. Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease.
Broquetas T; Herruzo-Pino P; Mariño Z; Naranjo D; Vergara M; Morillas RM; Forns X; Carrión JA
Liver Int; 2021 Nov; 41(11):2733-2746. PubMed ID: 34525253
[TBL] [Abstract][Full Text] [Related]
48. Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices.
Cassinotto C; Charrie A; Mouries A; Lapuyade B; Hiriart JB; Vergniol J; Gaye D; Hocquelet A; Charbonnier M; Foucher J; Laurent F; Chermak F; Montaudon M; de Ledinghen V
Dig Liver Dis; 2015 Aug; 47(8):695-701. PubMed ID: 25959234
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
Marri UK; Das P; Shalimar ; Kalaivani M; Srivastava DN; Madhusudhan KS
Radiology; 2021 Mar; 298(3):600-608. PubMed ID: 33399510
[TBL] [Abstract][Full Text] [Related]
50. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
Cho YS; Kim Y; Sohn JH
Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
[TBL] [Abstract][Full Text] [Related]
51. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference.
Kircheis G; Sagir A; Vogt C; Vom Dahl S; Kubitz R; Häussinger D
World J Gastroenterol; 2012 Mar; 18(10):1077-84. PubMed ID: 22416182
[TBL] [Abstract][Full Text] [Related]
53. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study.
Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X
Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627
[TBL] [Abstract][Full Text] [Related]
54. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.
Wong YJ; Zhaojin C; Tosetti G; Degasperi E; Sharma S; Agarwal S; Chuan L; Huak CY; Jia L; Xiaolong Q; Saraya A; Primignani M
Clin Mol Hepatol; 2023 Jan; 29(1):135-145. PubMed ID: 36064306
[TBL] [Abstract][Full Text] [Related]
55. Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B.
Ye XP; Ran HT; Cheng J; Zhu YF; Zhang DZ; Zhang P; Zheng YY
J Ultrasound Med; 2012 Aug; 31(8):1245-53. PubMed ID: 22837289
[TBL] [Abstract][Full Text] [Related]
56. Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease.
Shahrani S; Gill SS; Sooi CY; Skantha R; Kumar CVC; Limun MF; Affendi NANM; Chuah KH; Khoo S; Rajaram RB; Chan WK; Mahadeva S
J Gastroenterol Hepatol; 2023 Oct; 38(10):1818-1822. PubMed ID: 37587719
[TBL] [Abstract][Full Text] [Related]
57. Validation of a New Point Shear-Wave Elastography Method for Noninvasive Assessment of Liver Fibrosis: A Prospective Multicenter Study.
Joo I; Kim SY; Park HS; Lee ES; Kang HJ; Lee JM
Korean J Radiol; 2019 Nov; 20(11):1527-1535. PubMed ID: 31606957
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
[TBL] [Abstract][Full Text] [Related]
59. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
Podrug K; Trkulja V; Zelenika M; Bokun T; Madir A; Kanizaj TF; O'Beirne J; Grgurevic I
Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624
[TBL] [Abstract][Full Text] [Related]
60. Non-invasive diagnosis and follow-up of portal hypertension.
Thabut D; Weil D; Bouzbib C; Rudler M; Cassinotto C; Castéra L; Serste T; Oberti F; Ganne-Carrié N; de Lédinghen V; Bourlière M; Bureau C
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101767. PubMed ID: 34332128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
